Across TCGA pan-cancer cohorts, LINC01483 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated LINC01483 data layer.
The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher LINC01483 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC01483 expression acts as an unfavorable survival marker, although some lineages such as OV and THCA show a favorable association.
OV, KICH, and THCA are the cancer types where LINC01483 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.